Top Markets
#1 Islamic Coin Islamic Coin +151.46%
#2 DOVU DOVU +50.34%
#3 Velvet Velvet +40.04%
#4 Black Phoenix Black Phoenix +35.02%
#5 Fake World Assets Fake World Assets +19.47%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.10%
#7 Palladium Network Palladium Network +19.08%
#8 Akedo Akedo +17.40%
#9 DoubleZero DoubleZero +16.63%
#10 HOME HOME +13.53%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Ziccum AB (publ) Ziccum AB (publ)

Ziccum AB (publ)

ZICC
Rank in Stocks #39875
Ziccum AB (publ) specializes in creating stable dry powder formulations for... Ziccum AB (publ) specializes in creating stable dry powder formulations for biological pharmaceuticals. The company's core offering is LaminarPace, a proprietary spray drying technology they develop and commercialize. This innovative system enables the gentle, room-temperature drying of diverse substances, including chemicals, vaccines, biologics, and various other drug compounds. Established in 2017, Ziccum maintains its headquarters in Lund, Sweden.
Share Price
$0.02279104
Last synced: 2025-02-04
Market Cap
$315.99K
Change (1 day)
0.89%
Change (1 year)
0.00%
Country
SE
Trade Ziccum AB (publ) (ZICC)

Category

Healthcare
Revenue for Ziccum AB (publ) (ZICC)
Revenue in Sep 2024 TTM: $408.55K
According to Ziccum AB (publ) latest financial reports the company's current revenue (TTM) is $408.55K. In 2022 the company made a revenue of $1.63K an increase over the revenue in the year 2021 that was $552.48. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Ziccum AB (publ) from 2017 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $408.55K 10.00%
2023 $371.42K 22,681.73%
2022 $1.63K 195.09%
2021 $552.48 -8.68%
2020 $605.02 -99.14%
2019 $70.06K 175.72%
2018 $25.41K 0.00%
2017 0.00 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 3,089,951.82%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 1,473,731.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 2,474,718.79%
BE